Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
MALIGNANT OBSTRUCTIVE-JAUNDICE - PALLIATI VE TREATMENT WITH EXPANDABLE METALLIC STENTS
Autore:
ALDEANO A; SANZ C; FIGUERAS J; DOMINGUEZ J; SANCHO C; CABRERA LF; RAFECAS A; FABREGAT J; TORRAS J; MUNTANA X; JAURRIETA E;
Indirizzi:
CUIDAD SANITARIA & UNIV BELLVITGE,SERV CIRURGIA GEN & APARATO DIGEST,FEIXA LLARGA S-N E-08907 LHOSPITALET LLOBR SPAIN CUIDAD SANITARIA & UNIV BELLVITGE,SERV CIRURGIA GEN & APARATO DIGEST E-08907 LHOSPITALET LLOBR SPAIN
Titolo Testata:
Revista espanola de enfermedades digestivas
fascicolo: 9, volume: 87, anno: 1995,
pagine: 625 - 631
SICI:
1130-0108(1995)87:9<625:MO-PVT>2.0.ZU;2-O
Fonte:
ISI
Lingua:
SPA
Keywords:
MALIGNANT JAUNDICE; PALLIATIVE TREATMENT; EXPANDABLE METALLIC STENT;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Science Citation Index Expanded
Citazioni:
NO
Recensione:
Indirizzi per estratti:
Citazione:
A. Aldeano et al., "MALIGNANT OBSTRUCTIVE-JAUNDICE - PALLIATI VE TREATMENT WITH EXPANDABLE METALLIC STENTS", Revista espanola de enfermedades digestivas, 87(9), 1995, pp. 625-631

Abstract

Purpose: Study of the effectiveness and morbidity of palliative treatment of malignant obstructive jaundice with metallic biliary endoprosthesis compared to surgical palliation. Design: Retrospective review. Patients: 35 patients with non-resectable neoplasms causing jaundice were treated with percutaneous stent (pancreatic carcinoma, n=11; cholangiocarcinoma, n=11; gallbladder carcinoma, n=4; extrahepatic metastases of various malignancies, n=8). Control group: 23 patients with malignant jaundice treated with palliative surgery, Results: Most frequent complications were cholangitis and stent obstruction. The mean hospital stay after the stent placement was 6.8 days, longer in patients withcomplications (p=0.035), Recurrence of jaundice was seen in 22.9% of the patients and the rate of readmission was 42.9%, The mean survival was 163.33 days (range 19-522). Reduction in serum bilirubin after BE was significant (215 vs. 82 mmol/l, p<0.001), Conclusions: Comparing to our previous experience with surgical palliative treatment, there was no significant difference neither in morbimortality, nor recurrence or readmission. Patients with pancreatic cancer and cholangiocarcinomabenefit from a shorter hospital stay.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 03/04/20 alle ore 13:26:25